B. Braun Melsungen AG
https://www.bbraun.com/en.html
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From B. Braun Melsungen AG
China Market For Medtech: Opportunity Or Headache?
Medtech companies have typically seen a “mixed picture of growth” in China in the past year or two, but it is a market that requires ongoing commitment, a panel of experts argued at the MedTech Forum 2024.
Better Late Than Never: German Medtechs Make The Case For Practical MDR Improvements
A regulatory system that cannot function as intended, even with an extra year for preparation, will become mandatory in the EU next week. German medtechs suggest a route forward.
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Not Too Late? German Industry Presses For EU MRA With Post-Brexit UK
BVMed says the EU and the UK should set up a system of mutual recognition of medical device regulation to kick in when the UK’s EU exit transition period ends on 31 December.
Company Information
- Industry
- Distributors
- Medical Devices
-
Services
- Group Purchasing
- Home Infusion
-
Medical Devices
- Consumables, Central Supplies
- Implantable Devices
- Surgical Equipment & Devices
- Other Names / Subsidiaries
-
- Aesculap AG
- Aesculap Inc.
- Aesculap Implant Systems
- B. Braun Medical Inc.
- B. Braun Medical SAS
- B. Braun Miethke GmbH & Co. KG
- Central Admixture Pharmacy Services, Inc.
- Dextera Surgical, Inc.
- Lauer Membran Wassertechnik GmbH
- McGaw, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice